keyword
https://read.qxmd.com/read/38644702/the-effectiveness-of-parenteral-agents-for-pain-reduction-in-patients-with-migraine-presenting-to-emergency-settings-a%C3%A2-systematic-review-and-network-analysis
#1
REVIEW
Scott W Kirkland, Lloyd Visser, Jillian Meyer, Daniela R Junqueira, Sandra Campbell, Cristina Villa-Roel, Benjamin W Friedman, Nana Owusu Essel, Brian H Rowe
OBJECTIVES: To assess the comparative effectiveness and safety of parenteral agents for pain reduction in patients with acute migraine. BACKGROUND: Parenteral agents have been shown to be effective in treating acute migraine pain; however, the comparative effectiveness of different approaches is unclear. METHODS: Nine electronic databases and gray literature sources were searched to identify randomized clinical trials assessing parenteral agents to treat acute migraine pain in emergency settings...
April 2024: Headache
https://read.qxmd.com/read/38642233/peripheral-nerve-stimulation-in-postoperative-analgesia-a-narrative-review
#2
REVIEW
Alan D Kaye, Taylor R Plaisance, Summer A Smith, Amanda R Ragland, Michael J Alfred, Catherine G Nguyen, Azem A Chami, Saurabh Kataria, Kylie Dufrene, Sahar Shekoohi, Christopher L Robinson
PURPOSE OF REVIEW: Recent research has shown the effectiveness of peripheral nerve stimulators (PNS) in managing chronic pain conditions. Ongoing studies aim to explore its potential application in treating acute postoperative pain states. The purpose of this systematic review is to assess the role of PNS in providing relief for postoperative pain. RECENT FINDINGS: Clinical studies investigating the use of peripheral nerve stimulators (PNS) for analgesia following various surgeries, such as total knee arthroplasty, anterior cruciate ligament repair, ankle arthroplasty, rotator cuff repair, hallux valgus correction, and extremity amputation, have shown promising results...
April 20, 2024: Current Pain and Headache Reports
https://read.qxmd.com/read/38640323/radiofrequency-regulation-of-the-sphenopalatine-ganglion-in-managing-herpes-zoster-ophthalmicus-neuralgia-a-case-series
#3
JOURNAL ARTICLE
Min Cui, Na Zhang, Dong Wang, Lei Han
INTRODUCTION: Trigeminal herpes zoster, which comprises 10% to 20% of cases of herpes zoster, often leads to severe pain in the ophthalmic branches. Current treatments, including drug therapy and minimally invasive interventions, have limitations; accordingly, there is a need to explore alternative approaches. This study aimed to evaluate the efficacy and safety of computerized tomography (CT)-guided pulsed radiofrequency of the sphenopalatine ganglion in patients with intractable trigeminal herpetic pain...
April 19, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38635021/durable-effects-of-acupuncture-for-knee-osteoarthritis-a-systematic-review-and-meta-analysis
#4
REVIEW
He Chen, Hangyu Shi, Shuai Gao, Jiufei Fang, Jiamin Yi, Wenhui Wu, Xinkun Liu, Zhishun Liu
PURPOSE OF REVIEW: Knee osteoarthritis (KOA) is a degenerative joint disease which can result in chronic pain and disability. The current interventions available for KOA often fail to provide long-lasting effects, highlighting the need for new treatment options that can offer durable benefits. Previous studies have suggested the efficacy of acupuncture for knee osteoarthritis (KOA) with its durability remaining uncertain. In this review, we aimed to investigate the durability of the efficacy after completion of treatment...
April 18, 2024: Current Pain and Headache Reports
https://read.qxmd.com/read/38627638/rimegepant-orally-disintegrating-tablet-75%C3%A2-mg-for-acute-treatment-of-migraine-in-adults-from-china-a-subgroup-analysis-of-a-double-blind-randomized-placebo-controlled-phase-3-clinical-trial
#5
RANDOMIZED CONTROLLED TRIAL
Shengyuan Yu, Aihong Guo, Zhen Wang, Jianguang Liu, Ge Tan, Qian Yang, Mingjie Zhang, Hasiyeti Yibulaiyin, Huisheng Chen, Yongbo Zhang, Robert Croop, Yanhui Sun, Yu Liu, Qian Zhao, Zhihong Lu
BACKGROUND: Rimegepant orally disintegrating tablet (ODT), an oral small-molecule calcitonin gene-related peptide receptor antagonist, is indicated for acute and preventive treatment of migraine in the United States and other countries. Previously, a large clinical trial assessed the efficacy and safety of rimegepant ODT 75 mg for the acute treatment of migraine in adults living in China or South Korea. A post hoc subgroup analysis of this trial was performed to evaluate the efficacy and safety of rimegepant for acute treatment of migraine in adults living in China...
April 16, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38621710/large-skull-metastasis-in-follicular-thyroid-carcinoma-a-comprehensive-case-presentation-and-systematic-review
#6
JOURNAL ARTICLE
Gianluca Scalia, Massimiliano Porzio, Roberta Costanzo, Eliana Giurato, Fabio Gibilisco, Domenico Gerardo Iacopino, Rosario Maugeri, Giovanni Federico Nicoletti, Giuseppe Emmanuele Umana, Raffaele Alessandrello
BACKGROUND:  Skull metastases from follicular thyroid carcinoma (FTC) are infrequent but clinically significant, often presenting with localized pain, neurologic deficits, and cranial nerve dysfunction. Early detection and accurate diagnosis pose challenges due to their asymptomatic nature in some cases. METHODS:  A systematic literature review, conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, identified and analyzed 15 relevant studies focusing on large skull metastases in FTC...
April 15, 2024: Journal of Neurological Surgery. Part A, Central European Neurosurgery
https://read.qxmd.com/read/38609292/prehistoric-or-current-primitive-cranial-operations
#7
JOURNAL ARTICLE
Jeremy C Ganz
Humankind demonstrates boundless curiosity, mostly expressed through the activities of a small number of individuals, whose achievements affect all members of society. The extent and distribution of pre-historic trepanation and trepanation in contemporary unsophisticated societies are reviewed. In the great majority of cases the intention of trepanation has been therapeutic, even if the understanding of underlying pathophysiology is not the same as that which scientific societies now accept. This review demonstrates variation in surgical technique...
2024: Progress in Brain Research
https://read.qxmd.com/read/38590236/cost-effectiveness-of-rimegepant-oral-lyophilisate-compared-to-best-supportive-care-for-the-acute-treatment-of-migraine-in-the-uk
#8
JOURNAL ARTICLE
Karissa Johnston, Lauren C Powell, Evan Popoff, Gil J L'Italien, Robert Pawinski, Aideen Ahern, Sam Large, Thang Tran, Aaron Jenkins
AIMS: Migraine is the most common disabling headache disorder and is characterized by recurrent throbbing head pain and symptoms of photophobia, phonophobia, nausea, and vomiting. Rimegepant 75mg, an oral lyophilisate calcitonin gene-related peptide antagonist, is the first treatment approved for both the acute and preventative treatment of migraine, and the first acute therapy approved in over 20-years. The objective was to assess the cost-utility of rimegepant compared with best supportive care (BSC) in the UK, for the acute treatment of migraine in the adults with inadequate symptom relief after taking at least 2 triptans, or for whom triptans are contraindicated or not tolerated...
April 9, 2024: Journal of Medical Economics
https://read.qxmd.com/read/38540290/beyond-pain-relief-unveiling-the-multifaceted-impact-of-anti-cgrp-r-mabs-on-comorbid-symptoms-in-resistant-migraine-patients
#9
JOURNAL ARTICLE
Alessandra Della Vecchia, Ciro De Luca, Lucrezia Becattini, Letizia Curto, Elena Ferrari, Gabriele Siciliano, Sara Gori, Filippo Baldacci
The study aimed to evaluate the effects of monoclonal antibodies (mAbs) acting on the calcitonin gene-related peptide (CGRP) or its receptor (anti-CGRP/R mAbs) on migraine comorbidities of depression, anxiety, and fatigue in patients resistant to traditional therapies. The issue addressed in this study is pivotal to unveiling the role of this neurotransmitter beyond pain processing. We conducted an open-label prospective study assessing comorbidities in patients with high frequency (HFEM) and chronic migraine (CM), medication overuse headache (MOH), and resistance to traditional prophylaxis...
March 18, 2024: Biomedicines
https://read.qxmd.com/read/38538955/lumbar-percutaneous-transforaminal-endoscopic-discectomy-a-retrospective-survey-on-the-first-172-adult-patients-treated-in-denmark
#10
JOURNAL ARTICLE
Jacob Holmen Terkelsen, Torben Hundsholt, Carsten Reidies Bjarkam
PURPOSE: To evaluate patient demographics, surgery characteristics, and patient-reported clinical outcomes related to the implementation of lumbar PTED in Denmark by surgeons novice to the PTED technique. METHODS: All adult patients treated with a lumbar PTED from our first surgery in October 2020 to December 2021 were included. Data was generated by journal audit and telephone interview. RESULTS: A total of 172 adult patients underwent lumbar PTED...
March 27, 2024: Acta Neurochirurgica
https://read.qxmd.com/read/38533675/onabotulinumtoxina-as-a-promising-treatment-for-primary-trochlear-headache-a-retrospective-case-series
#11
JOURNAL ARTICLE
Alex Jaimes, Andrea Gómez, Olga Pajares, Jaime Rodríguez-Vico
OBJECTIVES: To report the efficacy of onabotulinumtoxinA (BoNTA) injections in relieving pain in patients with primary trochlear headache (PRTH). METHODS: Examination of medical records for patients diagnosed with PRTH according to the International Classification of Headache Disorders, 3rd edition criteria and treated with BoNTA. Data were collected for variables related to pain relief, duration of effectiveness, and adverse effects. RESULTS: Six patients were included in the study...
March 27, 2024: Headache
https://read.qxmd.com/read/38525832/readability-analysis-and-concept-mapping-of-proms-used-for-headache-disorders
#12
REVIEW
Merel H J Hazewinkel, Lisa Gfrerer, Sait Ashina, William G Austen, Anne F Klassen, Andrea Pusic, Manraj N Kaur
OBJECTIVE: To assess the readability and the comprehensiveness of patient-reported outcome measures (PROMs) utilized in primary headache disorders literature. BACKGROUND: As the health-care landscape has evolved toward a patient-centric model, numerous PROMs have been developed to capture treatment outcomes in patients with headache disorders. For these PROMs to advance our understanding of headache disorders and their treatment impact, they must be easy to understand (i...
March 25, 2024: Headache
https://read.qxmd.com/read/38523607/eptinezumab-for-the-preventive-treatment-of-episodic-and-chronic-migraine-a-narrative-review
#13
REVIEW
Pablo Irimia, Sonia Santos-Lasaosa, Patricia Pozo-Rosich, Rogelio Leira, Julio Pascual, José Miguel Láinez
Eptinezumab, a monoclonal antibody that targets calcitonin gene-related peptide (CGRP), was recently approved in Europe for the prophylactic treatment of migraine in adults who have at least four migraine days a month. Eptinezumab is administered by intravenous infusion every 12 weeks. During recent months, a considerable amount of evidence from eptinezumab trials has been published. The aim of this review is to describe the existing evidence on the tolerability, safety and efficacy of eptinezumab in patients with migraine...
2024: Frontiers in Neurology
https://read.qxmd.com/read/38518183/melatonin-in-hemicrania-continua-and-paroxysmal-hemicrania
#14
JOURNAL ARTICLE
Sing-Ngai Cheung, Renato Oliveira, Peter J Goadsby
BACKGROUND: Hemicrania continua (HC) and paroxysmal hemicrania (PH) belong to a group of primary headache disorders called trigeminal autonomic cephalalgias. One of the diagnostic criteria for both HC and PH is the absolute response to the therapeutic dose of indomethacin. However, indomethacin is discontinued in many patients as a result of intolerance to its side effects. Melatonin, a pineal hormone, which shares similar chemical structure to indomethacin, has been reported to have some efficacy for HC in previous case reports and series...
March 2024: Cephalalgia: An International Journal of Headache
https://read.qxmd.com/read/38512601/mitigating-factors-in-l4-and-l5-medial-branch-motor-stimulation-during-radiofrequency-ablation
#15
REVIEW
Mihir Jani, Nimesha Mehta, Sandra Yu, Ricky Ju, Ugur Yener, Alaa Abd-Elsayed, Lynn Kohan, Sayed Emal Wahezi
PURPOSE OF REVIEW: Radiofrequency ablation (RFA) is a minimally invasive procedure for facet joint pain. The targets for the procedure are the medial branches of the dorsal spinal nerves which innervate the facet joints. Before RFA, patients undergo diagnostic meal branch blocks to ensure appropriate pain relief and confirm the utility of proceeding to RFA. The success of RFA relies heavily on procedural technique and accurate placement near the medial branch. RECENT FINDINGS: Motor testing is utilized in the lumbar region to assess the response of the multifidus and ensure proper placement of the RFA probe to prevent inadvertent damage to surrounding spinal anatomy...
March 21, 2024: Current Pain and Headache Reports
https://read.qxmd.com/read/38506688/comparison-of-radiofrequency-ablation-and-craniotomy-microvascular-decompression-for-treatment-of-hemifacial-spasm
#16
JOURNAL ARTICLE
Huidan Lin, Shun Zhang, Xiang Gao, Lei Wu, Gang Cao, Lina Xuan, Yuyue Xun, Yongqing Liu, Changshun Huang, Bing Huang
BACKGROUND: Hemifacial spasm (HFS) is distinguished by sudden and involuntary spasms of the facial muscles, predominantly on one side of the face. Microvascular decompression (MVD) is an efficacious surgical technique for treating HFS; however, MVD may occasionally lead to noteworthy postoperative complications. Previously, we reported the successful utilization of an innovative awake computed tomography-guided percutaneous puncture of the stylomastoid foramen for administering radiofrequency ablation (RFA) therapy in the treatment of HFS...
March 2024: Pain Physician
https://read.qxmd.com/read/38505990/post-acute-covid-19-syndrome-in-previously-hospitalized-patients
#17
JOURNAL ARTICLE
Yoonsoo Eo, Sun Ju Chang
INTRODUCTION: With the prolongation of the COVID-19 pandemic, more individuals are experiencing sequelae after COVID-19 infection, also known as post-acute COVID-19 syndrome (PCS). The aims of this study were to describe the prevalence and characteristics of PCS symptoms such as fatigue, anxiety, and depression and to compare these symptoms according to participant characteristics in patients who had been previously hospitalized due to COVID-19. DESIGN: A descriptive cross-sectional study design was used...
March 20, 2024: Journal of Nursing Scholarship
https://read.qxmd.com/read/38463577/auricular-acupressure-combined-with-tongtian-oral-liquid-for-acute-attacks-of-migraine-without-aura-a-single-center-retrospective-study
#18
JOURNAL ARTICLE
Yuanyuan Wang, Zihan Rong, Pei Wang, Jiale Meng, Fei Yang, Ruiyi Xie, Zhaolu Deng, Sicheng Yuan, Tao Guo
OBJECTIVE: To observe the effect of auricular acupressure combined with Tongtian Oral Liquid for immediate pain relief in patients with acute migraine without aura, and to analyze the risk factors that affect the number of acute attacks of migraine without aura. METHODS: This retrospective study analyzed data of 180 patients diagnosed with acute migraine without aura who were admitted to Affiliated Hospital of Nanjing University of Chinese Medicine (Jiangsu Province Hospital of Chinese Medicine)...
2024: American Journal of Translational Research
https://read.qxmd.com/read/38460427/efficacy-of-greater-occipital-nerve-block-treatment-for-migraine-and-potential-impact-of-patient-positioning-during-procedure-results-of-randomised-controlled-trial
#19
JOURNAL ARTICLE
Jitka Vanderpol, Gina Kennedy, Fayyaz Ahmed, Leon Jonker
PURPOSE: Assess the efficacy, and potential impact of patient positioning for 10 minutes immediately post-procedure, of greater occipital nerve (GON) block for treatment of migraine. METHODS: Prospective multicentre non-blinded randomised controlled trial, randomisation and treatment of 60 neurology clinic patients with poorly controlled migraine. Outcomes measured with Headache Impact Test-6 (HIT-6), modified MIgraine Disability Assessment Scale (M-MIDAS), and RELIEF scores...
February 27, 2024: Clinical Neurology and Neurosurgery
https://read.qxmd.com/read/38435414/delayed-opportunities-for-patient-provider-communication-about-medication-overuse-headache-mixed-methods-perspectives-from-patients-and-neurologists
#20
JOURNAL ARTICLE
Allison Pack, Rachel O'Conor, Yvonne Curran, Wei Huang, Andrea Zuleta, Rodolfo Zuleta, Melissa P Herman, Steven M Kymes, Stacy C Bailey
OBJECTIVES: Medication overuse headache (MOH) is a common, debilitating condition occurring when migraine patients overuse pain relief medications. We conducted a convergent mixed methods study examining patient-provider communication on MOH. METHODS: Migraine patients were identified from one academic health center via electronic health records. Research staff recruited patients and administered a remote survey on MOH awareness, knowledge, and communication; descriptive and bivariate analyses were conducted...
April 2024: Preventive Medicine Reports
keyword
keyword
116908
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.